Matt Maloney, the co-founder and CEO of Chicago-based GrubHub Inc. (NYSE:GRUB) Seamless, and his wife paid $3.44 million this month for a six-bedroom, 7,000-square-foot vintage mansion in Lincoln Park. GrubHub Inc. (NYSE:GRUB) belongs to Technology sector. Its net profit margin is 4.80% and weekly performance is 0.51%. On last trading day company shares ended up $37.17. GrubHub Inc. (NYSE:GRUB) distance from 50-day simple moving average (SMA50) is -2.81%.

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) announced the presentation of results from a phase 2b dose-ranging study assessing plecanatide’s safety and efficacy in 424 adult patients (mITT population= 423) with irritable bowel syndrome with constipation (IBS-C). Data presented at ACG demonstrate that plecanatide, once-daily oral tablet, significantly improved complete spontaneous bowel movement (CSBM) frequency, bowel habits, treatment satisfaction and significantly reduced abdominal pain in patients with IBS-C throughout the 12 week treatment period. Notably, patients taking 3.0 and 9.0 mg plecanatide showed statistically significant improvement in the Overall Responder rate, a secondary analysis in this study and the endpoint required for FDA approval in IBS-C (41.9% and 40%, respectively, compared to 24.7% for placebo). Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) shares fell -4.56% in last trading session and ended the day at $2.72. SGYP return on assets is -102.60%. Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) quarterly performance is -27.85%.

On Oct. 14, Taylor Devices Inc. (NASDAQ:TAYD) announced that it had 1st quarter sales of $6,551,382, up significantly from last year’s 1st quarter sales of $5,296,666. On 22 October, Taylor Devices Inc. (NASDAQ:TAYD) shares increased 1.37% and was closed at $9.63. TAYD EPS growth in last 5 year was 13.60%. Taylor Devices Inc. (NASDAQ:TAYD) year to date (YTD) performance is 18.45%.

AMN Healthcare Services (NYSE:AHS) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research report issued to clients and investors on Monday. They currently have a $17.30 price objective on the stock. Zacks‘s price objective indicates a potential upside of 8.67% from the stock’s previous close. AMN Healthcare Services Inc. (NYSE:AHS) ended the last trading day at $16.62. Company weekly volatility is calculated as 2.76% and price to cash ratio as 140.51. AMN Healthcare Services Inc. (NYSE:AHS) showed a weekly performance of 3.94%.

On Oct 20, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that EYLEA Injection demonstrated a significantly greater improvement in mean change in best-corrected visual acuity from baseline at 52 weeks compared to both Avastin and Lucentis in a comparative study. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares increased 0.91% in last trading session and ended the day at $384.46. REGN Gross Margin is 88.20% and its return on assets is 12.90%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) quarterly performance is 26.28%.